Resurrecting hope for antioxidant treatment of cardiovascular disease: Focus on mitochondria

Circulation Research

Volumn 107, Issue 1, 2010, Pages 9-11

  O'Connor, Paul M ^a   Gutterman, David D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN II; ANTIMYCIN A1; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GP91DS TAT; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE; TEMPOL; UBIDECARENONE; UNCLASSIFIED DRUG;

ARTERIOLE; CARDIOVASCULAR DISEASE; CELL SURVIVAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; EDITORIAL; ELECTRON TRANSPORT; ENDOTHELIUM CELL; HERITABILITY; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY TUBULE EPITHELIUM; LYMPHOCYTIC INFILTRATION; MITOCHONDRIAL GENOME; MITOCHONDRION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SODIUM EXCRETION; T LYMPHOCYTE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77954723691     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.223321     Document Type: Editorial

References (39)

1. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI. Therapeutic targeting of mito-chondrial superoxide in hypertension. Circ Res. 2010;107:106-116.
2. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
3. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol. 2002;13:2860-2868.
4. Taylor NE, Glocka P, Liang M, Cowley AW Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension. 2006;47:692-698.
5. Taylor NE, Cowley AW Jr. Effect of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1573-R1579.
6. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38(3 Pt 2):606-611.
7. Moreno MU, San Jose G, Fortuno A, Beloqui O, Diez J, Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens. 2006;24:1299-1306.
8. Lacy F, O'Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998;16:291-303.
9. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endo-thelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 1997;96:1513-1519.
10. Natali A, Sironi AM, Toschi E, Camastra S, Sanna G, Perissinotto A, Taddei S, Ferrannini E. Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension. Arterioscler Thromb Vasc Biol. 2000;20:2401-2406.
11. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
12. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension. 2002;40:797-803.
13. Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Cavalera C. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients: Collaborative Group of the Primary Prevention Project (PPP)-Hypertension study. Am J Hypertens. 2000;13(5 Pt 1):564-567.
14. Larsen BT, Bubolz AH, Mendoza SA, Pritchard KA Jr, Gutterman DD. Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol. 2009;29:739-745.
15. Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal. 2009;11:791-810.
16. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790.
17. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 2009;23:2459-2466.
18. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF- 1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol. 2008;294:H570-H578.
19. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol. 2008;295:H1008-H1016.
20. Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation. 2006;113:1235-1243.
21. Ren Y, D'Ambrosio MA, Liu R, Pagano PJ, Garvin JL, Carretero OA. Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2010;298: H1769-H1775.
22. Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, Bauersachs J. Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension. 2009;54:338-344.
23. Chan SH, Wu KL, Chang AY, Tai MH, Chan JY. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension. 2009;53:217-227.
24. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008; 102:488-496.
25. Yang Q, Kim SK, Sun F, Cui J, Larson MG, Vasan RS, Levy D, Schwartz F. Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study. J Hypertens. 2007;25:2067-2073.
26. Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cocheme HM, Murphy MP, Dominiczak AF. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension. 2009;54:322-328.
27. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol. 2007;102: 255-260.
28. Peterson JR, Sharma RV, Davisson RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep. 2006;8:232-241.
29. O'Connor PM, Cowley AW Jr. Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep. 2010;12:86-92.
30. Guyton AC. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens. 1989;2:575-585.
31. O'Connor PM. Renal oxygen delivery: matching delivery to metabolic demand. Clin Exp Pharmacol Physiol. 2006;33:961-967.
32. O'Connor PM, Lu L, Liang M, Cowley AW Jr. A novel amiloride-sensitive h+ transport pathway mediates enhanced superoxide production in thick ascending limb of salt-sensitive rats, not NA+/H+ exchange. Hypertension. 2009;54:248-254.
33. O'Connor PM, Lu L, Schreck C, Cowley AW Jr. Enhanced amiloride-sensitive superoxide production in renal medullary thick ascending limb of Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2008;295: F726-F733.
34. Herrera M, Silva GB, Garvin JL. Angiotensin II stimulates thick ascending limb superoxide production via PKC{alpha}-dependent NADPH oxidase activation. J Biol Chem. 2010. May 6 [Epub ahead of print].
35. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol. 2002;283:F957-F962.
36. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na(+)-K(+)-2Cl(\) cotransporter activity. Am J Physiol Renal Physiol. 2001;281:F819-F825.
37. Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension. 2006;48:467-472.
38. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460. (Pubitemid 47529329)
39. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol. 2010;10:203-207.